세계의 인공 췌장 기기 시스템 시장

Global Artificial Pancreas Device Systems Market to Reach US$1.5 Billion by 2030

The global market for Artificial Pancreas Device Systems estimated at US$459.0 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 18.8% over the analysis period 2023-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Control-to-Target (CTT) Systems segment is estimated at 19.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$126.9 Million While China is Forecast to Grow at 17.8% CAGR

The Artificial Pancreas Device Systems market in the U.S. is estimated at US$126.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$230.2 Million by the year 2030 trailing a CAGR of 17.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 15.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.

Global Artificial Pancreas Device Systems Market - Key Trends and Drivers Summarized

How Are Artificial Pancreas Device Systems Transforming Diabetes Care?

Artificial pancreas device systems (APDS) have emerged as a groundbreaking advancement in diabetes care, particularly for those with Type 1 diabetes who require precise and continuous insulin management. These systems automate the process of insulin delivery by integrating continuous glucose monitors (CGMs) with insulin pumps and advanced algorithms, closely mimicking the function of a healthy pancreas. By maintaining glucose levels within a target range with minimal manual intervention, APDS significantly lighten the burden of diabetes management, leading to improved patient outcomes and an enhanced quality of life. As technology continues to advance, these systems are being hailed as the future of diabetes treatment, offering unmatched precision and control compared to traditional insulin administration methods.

What Technological Innovations Are Driving the Success of Artificial Pancreas Systems?

The success of artificial pancreas device systems has been largely driven by continuous technological innovations, particularly in sensor accuracy, algorithm sophistication, and seamless device integration. Recent improvements in CGM technology have resulted in sensors that provide highly accurate and reliable glucose readings with fewer calibrations, a critical component for the effectiveness of APDS. Advanced algorithms capable of predicting glucose trends and automatically adjusting insulin delivery in real-time have made these systems even more responsive to the body’s needs. The development of dual-hormone systems that administer both insulin and glucagon represents a promising leap forward, offering enhanced glucose control during exercise, illness, or other challenging conditions. These innovations have not only improved the efficacy of APDS but also made them more user-friendly and comfortable for everyday use.

What Emerging Trends Are Fueling the Adoption of Artificial Pancreas Systems?

A number of emerging trends are fueling the widespread adoption of artificial pancreas device systems, reflecting a broader shift toward more personalized and accessible diabetes care. The push for personalized medicine has led to the development of APDS tailored to the unique needs of individual patients, making these systems more effective and user-friendly. The rise of telemedicine and remote monitoring capabilities has also contributed to the growing popularity of APDS, as these technologies enable continuous glucose monitoring and insulin adjustments without the need for in-person visits. Additionally, expanded health insurance coverage for diabetes management devices is making APDS more accessible to a wider audience. The increasing prevalence of Type 1 diabetes, especially among younger populations, is further driving the demand for these systems as a means to improve long-term health outcomes and minimize the risks associated with poor glucose control.

Which Factors Are Fueling the Growth of the Artificial Pancreas Device Systems Market?

The growth in the artificial pancreas device systems market is fueled by several key factors that are shaping the future of diabetes management. The rising global prevalence of diabetes, particularly Type 1 diabetes, has created an urgent need for more precise and effective glucose management solutions. Technological advancements in continuous glucose monitoring, insulin pumps, and AI-driven algorithms have significantly improved the performance and reliability of APDS, making them more attractive to both patients and healthcare providers. The expansion of telehealth services and the increasing adoption of wearable health technologies are further boosting the market by providing more convenient and effective diabetes management options. Additionally, the growing emphasis on pediatric diabetes care is driving the development of more user-friendly and less invasive devices, broadening the market’s potential. As healthcare systems continue to prioritize value-based care, the ability of APDS to improve patient outcomes and reduce long-term diabetes management costs is expected to further propel the market’s growth.

Select Competitors (Total 47 Featured) -

• Beta Bionics, Inc.
• Bigfoot Biomedical, Inc.
• Johnson & Johnson
• Medtronic PLC
• Pancreum, Inc.
• Tandem Diabetes Care, Inc.
• TypeZero Technologies LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Artificial Pancreas Device Systems - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Diabetes Propels Growth in Artificial Pancreas Device Systems Market
  • Advancements in Continuous Glucose Monitoring (CGM) Drives Adoption
  • Integration of Insulin Pumps with Advanced Algorithms Expands Addressable Market Opportunity
  • Regulatory Approvals for Hybrid Closed-Loop Systems Propel Market Expansion
  • Improved Patient Outcomes with Automated Insulin Delivery Systems Spurs Growth
  • Increasing Adoption of Wearable Health Technology Drives Demand for Artificial Pancreas Devices
  • Innovation in Biocompatible Materials and Sensors Generates Opportunities for Enhanced Device Durability
  • Development of Dual-Hormone Systems Throws the Spotlight on Next-Generation Solutions
  • Rising Incidence of Type 1 Diabetes Among Youth Fuels Market Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World 7-Year Perspective for Artificial Pancreas Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 3: World Artificial Pancreas Device Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Threshold Suspended Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for Threshold Suspended Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Control-to-Target (CTT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for Control-to-Target (CTT) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Control-to-Range (CTR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Control-to-Range (CTR) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 10: USA Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 11: USA 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• CANADA
  • TABLE 12: Canada Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 13: Canada 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• JAPAN
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 14: Japan Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: Japan 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• CHINA
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 16: China Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: China 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• EUROPE
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 18: Europe Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 19: Europe 7-Year Perspective for Artificial Pancreas Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 20: Europe Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Europe 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• FRANCE
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 22: France Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: France 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• GERMANY
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 24: Germany Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Germany 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• ITALY
  • TABLE 26: Italy Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Italy 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• UNITED KINGDOM
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 28: UK Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: UK 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 30: Rest of Europe Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: Rest of Europe 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• ASIA-PACIFIC
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 32: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Asia-Pacific 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 34: Rest of World Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: Rest of World 7-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2024 & 2030

IV. COMPETITION